Results 221 to 230 of about 807,862 (404)

Characteristics and outcomes of Bahraini pediatric patients sent abroad for bone marrow transplantation: A ten-year retrospective cohort study. [PDF]

open access: yesWorld J Transplant
Isa HM   +7 more
europepmc   +1 more source

Solid cancers after bone marrow transplantation.

open access: yesNew England Journal of Medicine, 1997
R. Curtis   +18 more
semanticscholar   +1 more source

Pure Red Cell Aplasia Associated With Thymic Tumors, a Nationwide Retrospective Study

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Pure red cell aplasia (PRCA) is the most frequent autoimmune cytopenia associated with thymic tumors (TTs). In a nationwide retrospective study, we included 41 patients (22 women, median age 62 years). At PRCA diagnosis, the mean hemoglobin level was 6.6 ± 2.1 g/dL, and the reticulocyte count was 6 ± 5 × 109/L. PRCA was diagnosed before TT (8%,
Mylène Hemmer   +9 more
wiley   +1 more source

Cell migration, chimerism, and graft acceptance: with particular reference to the liver [PDF]

open access: yes, 1996
Demetris, AJ   +4 more
core  

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

open access: yesNew England Journal of Medicine, 2004
M. Laughlin   +13 more
semanticscholar   +1 more source

Similar Outcome With Haploidentical, Matched Sibling, or Matched Unrelated Donor Hematopoietic Cell Transplantation for Adult Patients With Adverse‐Risk TP53‐Mutated Acute Myeloid Leukemia in First Remission: A Comparative Study From the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Given the dismal prognosis for patients with TP53‐mutated acute myeloid leukemia (AML), the optimal donor for those undergoing allogeneic hematopoietic cell transplantation (allo‐HCT) remains unclear. We retrospectively analyzed adult patients with TP53‐mutated AML who underwent first allo‐HCT in CR1 between 2010 and 2021.
Yuhua Ru   +13 more
wiley   +1 more source

Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantation. [PDF]

open access: yesBMC Cancer
Pituskin E   +24 more
europepmc   +1 more source

IMMUNOCOMPETENCE FOLLOWING ALLOGENEIC BONE MARROW TRANSPLANTATION IN MAN

open access: bronze, 1972
Roger H. Halterman   +3 more
openalex   +1 more source

Home - About - Disclaimer - Privacy